A Toxicogenic Interaction between Intracellular Amyloid-β and Apolipoprotein-E.
Arpan DeyAditi VermaUchit BhaskarBidyut SarkarMamata KallianpurVicky VishvakarmaAnand Kant DasKanchan GaraiOdity MukherjeeKunihiko IshiiTahei TaharaSudipta MaitiPublished in: ACS chemical neuroscience (2024)
Alzheimer's disease (AD) is associated with the aggregation of amyloid β (Aβ) and tau proteins. Why ApoE variants are significant genetic risk factors remains a major unsolved puzzle in understanding AD, although intracellular interactions with ApoE are suspected to play a role. Here, we show that specific changes in the fluorescence lifetime of fluorescently tagged small Aβ oligomers in rat brain cells correlate with the cellular ApoE content. An inhibitor of the Aβ-ApoE interaction suppresses these changes and concomitantly reduces Aβ toxicity in a dose-dependent manner. Single-molecule techniques show changes both in the conformation and in the stoichiometry of the oligomers. Neural stem cells derived from hiPSCs of Alzheimer's patients also exhibit these fluorescence lifetime changes. We infer that intracellular interaction with ApoE modifies the N-terminus of the Aβ oligomers, inducing changes in their stoichiometry, membrane affinity, and toxicity. These changes can be directly imaged in live cells and can potentially be used as a rapid and quantitative cellular assay for AD drug discovery.
Keyphrases
- cognitive decline
- single molecule
- high fat diet
- induced apoptosis
- mild cognitive impairment
- drug discovery
- risk factors
- end stage renal disease
- cell cycle arrest
- neural stem cells
- chronic kidney disease
- reactive oxygen species
- ejection fraction
- atomic force microscopy
- copy number
- prognostic factors
- high throughput
- peritoneal dialysis
- type diabetes
- gene expression
- insulin resistance
- adipose tissue
- pi k akt
- patient reported